|
|
|
|
| Cat. No. 371 011C2 |
100 µg purified IgG, lyophilized, fluorescence-labeled with
Cyanine 2.
Albumin was added for stabilization. For reconstitution add 100 µl H2O to get a 1mg/ml solution in PBS. Either add 1:1 (v/v) glycerol, then aliquot and store at -20°C until use, or store aliquots at -80°C without additives. Reconstitute immediately upon receipt! Avoid bright light when working with the antibody to minimize photo bleeching of the fluorescent dye. |
| Applications |
IP: N/A ICC: 1 : 250 up to 1 : 1000 gallery IHC: not tested yet IHC-P (FFPE): not tested yet FACS: yes |
| Label | Cyanine 2 |
| Clone | 101G9 |
| Subtype | IgG2b (κ light chain) |
| Immunogen | Purified human basophil granulocytes. (UniProt Id: P08962) |
| Epitop |
AA 103 to 203 from human CD63 (UniProt Id: P08962) |
| Reactivity |
Reacts with: human (P08962). Other species not tested yet. |
| Data sheet | Data Sheet 371_011c2 |
|
|
CD63, also known as melanoma-associated antigen ME491, is a member of the tetraspanin superfamily, which is characterized by proteins containing four transmembrane domains (1). CD63 is extensively N-glycosylated and is predominantly localized to late endosomes, lysosomes, secretory vesicles, and the plasma membrane (1–3). It is ubiquitously expressed in normal tissues and is markedly upregulated in activated basophils and mast cells, where it is required for efficient IgE-mediated degranulation (4,5).
In melanoma, CD63 is highly expressed during early stages of disease, where it has been implicated in the suppression of epithelial-to-mesenchymal transition (EMT); however, its expression is reduced in more advanced lesions (6). In addition, CD63 expression has been reported to possess prognostic significance in several other solid tumors (7).